JAK
Janus kinases (JAKs), belonging to a distinct family of tyrosine kinases, are non-receptor tyrosine kinases that transduce signals of cytokine receptors via diverse signal transduction pathways. Mammalian JAK family consists of four structurally similar members, JAK1, JAK2, JAK3 and Tyrosine kinase 2 (TYK2), which are characterized by containing seven JAK homology (JH) domains. The presence of JH1 and JH2 domains is the most intriguing feature of JAK proteins. JH1 domain is the main catalytic domain; while JH2 is usually considered as a catalytically inactive pseudokinase domain. However, results of recent studies have shown that JH2 acts as a dual-specificity protein kinase to phosphorylate two regulatory sites (Ser523 and Tyr570) in JAK2.
Products for JAK
- Cat.No. Product Name Information
-
BCC1276
Ruxolitinib (INCB018424)JAK inhibitor
-
BCC1400
Bardoxolone methylIKK inhibitor, potent antioxidant inflammation modulator
-
BCC1401
Baricitinib phosphateJAK1/JAK2 inhibitor
-
BCC1506
CYT387 sulfate saltJAK1/JAK2 inhibitor
-
BCC1667
JAK2 Inhibitor V, Z3Jak2 tyrosine kinase inhibitor
-
BCC1668
JANEX-1JAK3 inhibitor
-
BCC1815
NVP-BSK805ATP-competitive JAK2 inhibitor
-
BCC1874
Pyridone 6Pan-JAK inhibitor
-
BCC1912
Ruxolitinib phosphateJAK1/JAK2 inhibitor
-
BCC1913
Ruxolitinib sulfateJAK inhibitor
-
BCC1925
SB1317CDK,JAK and FLT inhibitor
-
BCC2056
WHI-P97Janus kinase (JAK)-3 inhibitor
-
BCC2057
XL019JAK2 inhibitor,potent and selective
-
BCC2189
Tofacitinib (CP-690550) CitratePotent JAK inhibitor
-
BCC2190
TG101348 (SAR302503)JAK-2 inhibitor,potent and selective
-
BCC2191
AZD1480Potent and selective JAK2 inhibitor; antiangiogenic
-
BCC2192
Tofacitinib (CP-690550,Tasocitinib)Janus kinase inhibitor
-
BCC2195
Baricitinib (LY3009104, INCB028050)JAK1/JAK2 inhibitor,selective orally bioavailable
-
BCC2196
CYT387JAK-1/-2 inhibitor,ATP competitive
-
BCC2197
AZ 960JAKs inhibitor
-
BCC2199
CEP-33779JAK2 inhibitor,highly selective
-
BCC2200
LY2784544JAK2 inhibitor,highly potent and selective
-
BCC2201
S-Ruxolitinib (INCB018424)JAK1/2 inhibitor,potent and selective
-
BCC2437
1,2,3,4,5,6-HexabromocyclohexaneInhibits JAK2 autophosphorylation
-
BCC2438
CercosporamidePotent Mnk2 inhibitor; also inhibits JAK3
-
BCC2440
LestaurtinibJAK2/FLT3/TrkA inhibitor
-
BCC2441
NSC 33994JAK2 inhibitor
-
BCC2442
SD 1008JAK2/STAT3 signaling pathway inhibitor
-
BCC2443
TCS 21311JAK3 inhibitor
-
BCC2444
ZM 449829Potent, selective JAK3 inhibitor
-
BCC4145
GLPG0634JAK1 inhibitor
-
BCC6456
Decernotinib(VX-509)Selective and orally active JAK3 inhibitor
-
BCC6503
Peficitinb (ASP015K, JNJ-54781532)JAK inhibitor
-
BCC8068
Cerdulatinib (PRT062070)Syk/JAK inhibitor